GCP
WVE icon

GSA Capital Partners’s Wave Life Sciences WVE Stock Holding History

GSA Capital Partners’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.08M Sell
185,959
-96,760
-34% -$642K 0.07% 457
2026
Q1 		$2.05M Buy
+282,719
New +$3.68M 0.13% 160
2025
Q4 		– Sell
-51,198
Closed -$375K – 2144
2025
Q3 		$375K Buy
+51,198
New +$414K 0.03% 1059
2025
Q2 		– Sell
-12,643
Closed -$102K – 2203
2025
Q1 		$102K Buy
+12,643
New +$138K 0.01% 1494
2024
Q4 		– Sell
-63,513
Closed -$521K – 2077
2024
Q3 		$521K Buy
63,513
+8,255
+15% +$49.3K 0.04% 870
2024
Q2 		$276K Sell
55,258
-39,779
-42% -$227K 0.02% 1314
2024
Q1 		$586K Buy
+95,037
New +$476K 0.05% 789
2023
Q3 		– Sell
-83,210
Closed -$303K – 1964
2023
Q2 		$303K Buy
+83,210
New +$336K 0.03% 1045
2022
Q2 		– Sell
-196,887
Closed -$394K – 1853
2022
Q1 		$394K Buy
196,887
+23,242
+13% +$56.9K 0.05% 711
2021
Q4 		$545K Buy
173,645
+140,876
+430% +$585K 0.07% 537
2021
Q3 		$161K Buy
+32,769
New +$199K 0.02% 1276
2018
Q4 		– Sell
-7,600
Closed -$380K – 1787
2018
Q3 		$380K Sell
7,600
-1,900
-20% -$85.7K 0.02% 1211
2018
Q2 		$363K Sell
9,500
-10,600
-53% -$456K 0.02% 1306
2018
Q1 		$806K Buy
20,100
+9,200
+84% +$387K 0.04% 797
2017
Q4 		$383K Buy
+10,900
New +$318K 0.02% 1083

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

GSA Capital Partners's WVE Position: Q2 2026 in Review

GSA Capital Partners reduced its Wave Life Sciences (WVE) stake by 34% in Q2 2026, selling an estimated $642K and leaving 185,959 shares worth $1.08M. The position accounts for 0.07% of the portfolio, ranked #457.

GSA Capital Partners first reported a position in WVE in Q4 2017 and has held it in 15 quarters since. The position peaked at $2.05M in Q1 2026. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • GSA Capital Partners held 185,959 shares of Wave Life Sciences worth $1.08M as of Q2 2026.
  • GSA Capital Partners sold 96,760 Wave Life Sciences shares in Q2 2026, an estimated $642K.
  • Wave Life Sciences made up 0.07% of GSA Capital Partners's portfolio in Q2 2026, its #457 holding.
  • GSA Capital Partners first reported a position in Wave Life Sciences in Q4 2017 and has held it in 15 quarters since.
  • GSA Capital Partners's Wave Life Sciences position peaked at $2.05M in Q1 2026.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.